From January 1, 2023 to March 22, 2023, the company has repurchased 331,100 shares, representing 0.9% for ¥1,122.92 million. With this, the company has completed the repurchase of 1,036,200 shares, representing 2.78% for ¥3,499.72 million under the buyback announced on August 1, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3,150 JPY | -2.48% | -1.25% | -3.67% |
04-25 | Hidehiro Imatsu named president of Goldman Sachs Japan | RE |
03-21 | Tranche Update on Mochida Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 15, 2023. | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.67% | 735M | |
+29.21% | 684B | |
+30.34% | 568B | |
-3.85% | 361B | |
+17.64% | 329B | |
+4.29% | 284B | |
+16.21% | 240B | |
+9.66% | 208B | |
-6.83% | 200B | |
+7.26% | 166B |
- Stock Market
- Equities
- 4534 Stock
- News Mochida Pharmaceutical Co., Ltd.
- Tranche Update on Mochida Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on August 1, 2022.